Clinical study on the treatment of high-risk BPH with hermo-expandable metallic prostate stent
10.16571/j.cnki.1008-8199.2020.04.012
- VernacularTitle: 热膨胀螺旋形前列腺支架治疗高危前列腺增生的临床效果分析
- Author:
Song XUE
1
;
Jing-ping GE
1
;
Shui-gen ZHOU
1
;
Hao TANG
1
;
Le QU
1
;
Feng XU
1
;
Xiao-ming YI
1
;
Song XU
1
;
Hao-wei HE
1
Author Information
1. Department of Urology,General Hospital of Eastern Theater Command,PLA,Nanjing 210002,Jiangsu,China
- Publication Type:Journal Article
- Keywords:
thermoexpandable metallic prostate stent;
benign prostatic hyperplasia;
curative effect
- From:
Journal of Medical Postgraduates
2020;33(4):404-407
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the clinical efficacy and surgical experience of hermo-expandable metallic prostate stent in the treatment of elderly high-risk BPH patients.MethodsRetrospective analysis was performed on 38 patients with BPH who underwent implantation of hermo-expandable metallic prostate stent from January 2017 to October 2018 in the General Hospital of Eastern Theater Command. The patients were 72 to 89 years old, with preoperative international prostatic symptom score (IPSS) of 25.6±4.1 points, maximum flow rate of urine (MRF) of (4.8±1.2) mL/s, and residual urine volume (RUV) (160.7±70.5) mL. Urinary catheters were placed in 7 patients for 4-8 days due to acute urinary retention.ResultsExcept for the failure in one case, all 37 patients were successfully implanted with the prostate stent at one time, and they urinated immediately after the operation without serious operation-related complications. Follow-up was conducted for 3 months, and the IPSS and RUV of the 37 patients were (15.6±4.3) and (40.7±12.9) mL respectively, which were significantly lower than those before the operation (P<0.05). MRF was (11.1±4.3) mL/s, significantly higher than that before surgery (P<0.05). 22 cases in this group were followed up for 2 years, and their IPSS, MRF and RUV were all stable.ConclusionThe thermo-expandable metallic prostate stent for the treatment of dysuria caused by BPH is effective, reliable and less traumatic. It is a preferred choice for the treatment of the aged BPH patients who are at a high risk and not suitable for surgery.
